Related Experiment Videos
mRNA expression of tumor-associated antigens in melanoma tissues and cell lines
Stefan Eichmüller1, Dirk Usener, Anita Jochim
1German Cancer Research Center (DKFZ), Skin Cancer Unit (D0900), Im Neuenheimer Feld 280, Heidelberg, Germany. s.eichmueller@dfkz.de
Abstract:
Tumor-associated antigens (TAA) are increasingly used as specific targets for immune therapy of malignant melanoma. The aim of the present study was to provide a basis for selecting the most suitable TAA by analyzing the mRNA expression of a large panel of TAA by RT-PCR and Northern blotting. We have chosen primers differentiating four groups of TAA (MAGE-A, MAGE-B, and two groups of GAGE-genes) and 13 individual TAA (MAGE-A2 and -A3, RAGE-1, -2, -3, and -4, LAGE-1a and -1b, NY-ESO-1, GAGE-1, SSX-2, SCP-1, and cTAGE-1) based on most recent sequence data. In addition, the RAGE-gene family has been separated into its four members by a novel designed nested PCR, which was confirmed by Northern analysis. Furthermore, the chromosomal organization and relationship between the RAGE-family and MOK was analyzed. RAGE-4 mRNA could be shown for the first time to be present in testis tissue. The most frequently expressed TAA were the MAGE-A and the GAGE-3,-4,-5,-6,-8 group, whereas among individual TAA MAGE-A2, -A3, RAGE-1, -3, and LAGE-1a/b were found within most specimens and are thus promising candidates for immune therapy. In comparison, melanoma metastatic specimens and cell lines show similar profiles of TAA expression, but individual TAA differ notably between both types of samples indicating that results from cell lines are not always applicable to tumor specimen.
Insights
Researchers analyzed messenger RNA (mRNA) expression of tumor-associated antigens (TAA) in melanoma to identify promising targets for immune therapy. MAGE-A and GAGE genes, along with specific individual TAAs like MAGE-A2 and RAGE-1, showed frequent expression, indicating their potential for therapeutic development.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Tumor-associated antigens (TAA) are crucial targets for melanoma immune therapies.
- Selecting optimal TAAs requires understanding their expression patterns.
Purpose of the Study:
- To analyze mRNA expression of a broad panel of TAAs in melanoma.
- To identify the most suitable TAAs for immune therapy based on expression data.
Main Methods:
- RT-PCR and Northern blotting were used to analyze mRNA expression.
- Primers were designed for MAGE-A, MAGE-B, GAGE gene groups, and 13 individual TAAs.
- Novel nested PCR differentiated RAGE-gene family members.
Main Results:
- MAGE-A and GAGE-3,-4,-5,-6,-8 groups were frequently expressed.
- MAGE-A2, -A3, RAGE-1, -3, and LAGE-1a/b were identified as promising individual TAA candidates.
- RAGE-4 mRNA was detected in testis tissue for the first time.
- TAA expression profiles in metastatic melanoma specimens and cell lines were similar but showed notable individual TAA differences.
Conclusions:
- MAGE-A, GAGE, and specific individual TAAs are promising targets for melanoma immunotherapy.
- Melanoma cell lines may not fully represent TAA expression in tumor specimens.
- Further research is needed to validate these findings for clinical application.